echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Announcement of the State Food and Drug Administration: 16 batches of drugs are unqualified

    Announcement of the State Food and Drug Administration: 16 batches of drugs are unqualified

    • Last Update: 2021-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 10, the State Food and Drug Administration issued a notice that 16 batches of drugs did not meet the requirements


    Unqualified varieties:

    Solid preparations: compound clotrimazole cream (2 batches), Gucining capsules, joint pain ointment (3 batches), Huanglian Shangqing pills, Keteling capsules, Jiawei Huoxiang Zhengqi pills

    Chinese herbal medicine pieces: Qingfengzi (3 batches), Bupleurum (3 batches), Bupleurum (North Bupleurum)

    Unqualified test items:

    Solid preparations: microbial limit (2 batches), loading water, content determination, loading difference, identification


    Chinese herbal medicine pieces: traits (6 batches), impurities

    The following is the original text:

    After inspection by 8 drug inspection institutions including Anhui Food and Drug Inspection and Research Institute, 16 batches of drugs including compound clotrimazole cream produced by 14 companies including Hebei Jiuzheng Pharmaceutical Co.


    1.


    After inspection by Shanxi Provincial Food and Drug Inspection Institute, it is indicated that the entrusting party is Shanxi Tianzhi Pharmaceutical Co.


    The three batches of joint pain relief ointment produced by Jiangsu Baiyi Pharmaceutical Co.


    A batch of Huanglian Shangqing Pills produced by Sichuan Qiyun Pharmaceutical Co.


    After inspection by the Tibet Autonomous Region Food and Drug Inspection and Research Institute, a batch of Keteling capsules produced by Yili Pharmaceutical Co.


    After inspection by Wuhan Institute of Drug and Medical Device Inspection, a batch of Jiawei Huoxiang Zhengqi Pills produced by Guangzhou Yuehua Pharmaceutical Co.


    After inspection by China National Institute for Food and Drug Control, the three batches of argentea produced by Anhui Jiancheng Chinese Medicine Decoction Pieces Co.


    According to the inspection by Gansu Provincial Institute of Drug Inspection, the 2 batches of Bupleurum spp.


    2.


    3.


    Hereby inform


    Appendix:

    1.


    2.


    State Food and Drug Administration

    June 8, 2021

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.